Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BKR vs GSK✓SelectedUSD · GSKBKR vs GSK performance historyLatest closeAs of-3.99%11/20
Stock and ETF performance explorer

BKR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+371.4%
GSK return
+1,644.3%
Excess return
-1,272.9%
Maximum drawdown
-83.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.0%-0.1%-3.9%-3.9%
7D-9.4%-5.3%-4.0%-7.8%
30D-19.6%-3.7%-15.9%-18.8%
3M-28.3%-7.3%-21.0%-26.9%
6M-32.3%-4.2%-28.1%-32.0%
YTD-0.1%+0.9%-0.9%-1.7%
1Y-5.3%+7.3%-12.6%-8.8%
3Y+40.8%+52.7%-11.9%+18.0%
5Y+122.3%+40.1%+82.2%+88.8%
10Y+36.6%+98.7%-62.1%+2.8%
All+371.4%+1,644.3%-1,272.9%+144.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling